Subscribe to RSS
DOI: 10.1055/s-0030-1261034
Parallel Synthesis of 1-Substituted 5-(5-Oxopyrrolidin-3-yl)-1H-pyrazole-4-carboxamides
Publication History
Publication Date:
08 August 2011 (online)
Abstract
A parallel solution-phase synthesis of 5-(5-oxo-1-phenylpyrrolidin-3-yl)-1H-pyrazole-4-carboxamide derivatives as conformationally constrained pyrazole analogues of histamine starting from itaconic acid was developed. The synthetic method comprises a five-step preparation of 1-substituted 5-(5-oxo-1-phenylpyrrolidin-3-yl)-1H-pyrazole-4-carboxylic acids followed by parallel amidation with various primary and secondary amines to give a library of 24 histamine analogues in good overall yields and in very high purities. The method is general and substrate-independent. All the amidations proceed smoothly and no major difference in reactivity is observed with respect to the structures of the reactants.
Key words
pyrrolidinone - pyrazole - cyclocondensations - amidations - histamine analogues
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Dolle RE. Solid-Phase Synthesis of Heterocyclic Systems (Heterocycles Containing One Heteroatom), In Handbook of Combinatorial Chemistry. Drugs, Catalysts, Materials Vol. 2:Nicolaou KC.Hanko R.Hartwig W. Wiley-VCH; Weinheim: 2002. p.643 -
1b
Pernerstorfer J. Molecular Design and Combinatorial Compound Libraries, In Handbook of Combinatorial Chemistry. Drugs, Catalysts, Materials Vol. 2:Nicolaou KC.Hanko R.Hartwig W. Wiley-VCH; Weinheim: 2002. p.725 -
2a
Dolle RE.Le Bourdonnec B.Morales GA.Moriarty KJ.Salvino JM. J. Comb. Chem. 2008, 10: 753 -
2b
Dolle RE.Le Bourdonnec B.Goodman AJ.Morales GA.Thomas CJ.Zhang W. J. Comb. Chem. 2009, 11: 739 -
2c
Dolle RE.Le Bourdonnec B.Worm K.Morales GA.Thomas CJ.Zhang W. J. Comb. Chem. 2010, 12: 765 ; and references cited therein -
3a
Patrick GL. In An Introduction to Medicinal Chemistry 3rd ed.: Oxford University Press; Oxford: 2005. -
3b
Kazuta Y.Hirano K.Natsume K.Yamada S.Kimura R.Matsumoto S.-i.Furuichi K.Matsuda A.Shuto S. J. Med. Chem. 2003, 46: 1980 -
3c
Liebscher J.Patzel M. Synlett 1994, 471 -
3d
Elsner J.Boeckler F.Davidson K.Sugden D.Gmeiner P. Bioorg. Med. Chem. 2006, 14: 1949 -
3e
Nenajdenko VG.Zakurdaev EP.Gololobov AM.Balenkova ES. Russ. Chem. Bull. 2005, 54: 220 -
3f
Marshall DR.Rodriguez G.Thomson DS.Nelson R.Capolina A. Bioorg. Med. Chem. Lett. 2007, 17: 315 - 4
Svete J. In (4R*,5R*)-4-Benzoylamino-5-phenyl-3-pyrazolidinone - A Useful Building Block in the Synthesis of Functionalized PyrazolesHorvat MA.Golob JH. Nova Science Publishers, Inc.; New York: 2008. p.129 ; (open access item: the pdf is available at https://www.novapublishers.com/catalog/product_info.php?products_id=16416), and references cited therein - 5
Stanovnik B.Svete J. Chem. Rev. 2004, 104: 2433 ; and references cited therein -
6a
Pezdirc L.Cerkovnik J.Pirc S.Stanovnik B.Svete J. Tetrahedron 2007, 63: 991 -
6b
Pezdirc L.Bevk D.Grošelj U.Meden A.Stanovnik B.Svete J. J. Comb. Chem. 2007, 9: 717 -
7a
Bienayme H. Tetrahedron Lett. 1998, 39: 4255 -
7b
Lorthioir O.McKeown SC.Parr NJ.Washington M.Watson SP. Tetrahedron Lett. 2000, 41: 8609 -
7c
Westman J.Lundin R.Stalberg J.Ostbye M.Franzen A.Hurynowicz A. Comb. Chem. High Throughput Screening 2002, 5: 565 -
7d
Henkel B.Sax M.Dömling A. Tetrahedron Lett. 2003, 44: 3679 -
7e
Westman J.Lundin R. Synthesis 2003, 1025 -
7f
Čebašek P.Wagger J.Bevk D.Jakše R.Svete J.Stanovnik B. J. Comb. Chem. 2004, 6: 356 -
7g
Schwalbe T.Kadzimirsz D.Jas G. QSAR Comb. Sci. 2005, 24: 758 -
7h
Čebašek P.Bevk D.Pirc S.Stanovnik B.Svete J. J. Comb. Chem. 2006, 8: 95 -
7i
Malavašič Č.Brulc B.Čebašek P.Dahmann G.Heine N.Bevk D.Grošelj U.Meden A.Stanovnik B.Svete J. J. Comb. Chem. 2007, 9: 219 -
7j
Baškovč B.Bevk D.Stanovnik B.Svete J. J. Comb. Chem. 2009, 11: 500 -
7k
Pellegrino G.Leonetti F.Carotti A.Nicolotti O.Pisani L.Stefanachi A.Catto M. Tetrahedron Lett. 2010, 51: 1702 -
7l
Hernandez S.Moreno I.SanMartin R.Gomez G.Herrero MT.Dominguez E. J. Org. Chem. 2010, 75: 434 -
8a
Wyatt PG.Allen MJ.Chilcott J.Foster A.Livermore DG.Mordaunt JE.Scicinski J.Woollard PM. Bioorg. Med. Chem. Lett. 2002, 12: 1399 -
8b
Manley PW.Breitenstein W.Brueggen J.Cowan-Jacob SW.Furet P.Mestan J.Meyer T. Bioorg. Med. Chem. Lett. 2004, 14: 5793 -
8c
Gopalsamy A.Yang H.Ellingboe JW.Tsou H.-R.Zhang N.Honores E.Powell D.Miranda M.McGinnis JP.Rabindran SK. Bioorg. Med. Chem. Lett. 2005, 15: 1591 -
8d
Kalesh KA.Liu K.Yao SQ. Org. Biomol. Chem. 2009, 7: 5129 -
8e
Yang W.Ruan Z.Wang Y.Van Kirk K.Ma Z.Arey BJ.Cooper CB.Seethala R.Feyen JHM.Dickson JK. J. Med. Chem. 2009, 52: 1204 -
8f
Yang FV.Shipe WD.Bunda JL.Nolt MB.Wisnoski DD.Zhao Z.Barrow JC.Ray WJ.Ma L.Wittmann M.Seager MA.Koeplinger KA.Hartman GD.Lindsley CW. Bioorg. Med. Chem. Lett. 2010, 20: 531 - 9
Kralj D.Grošelj U.Meden A.Dahmann G.Stanovnik B.Svete J. Tetrahedron 2007, 63: 11213 - 10
Kralj D.Novak A.Dahmann G.Grošelj U.Meden A.Svete J. J. Comb. Chem. 2008, 10: 664 - 11
Kralj D.Friedrich M.Grošelj U.Kiraly-Potpara S.Meden A.Wagger J.Dahmann G.Stanovnik B.Svete J. Tetrahedron 2009, 65: 7151 - 12
erovnik D.Grošelj U.Kralj D.Malavašič Č.Bezenšek J.Dahmann G.Stare K.Meden A.Stanovnik B.Svete J. Synthesis 2010, 3363 - 13
Janjić M.Grošelj U.Kralj D.Malavašič Č.Golobič A.Stare K.Dahmann G.Stanovnik B.Svete J. Helv. Chim. Acta 2011, 94: in press; DOI: 10.1002/hlca.201100055 - 14
Paytash PL.Sparrow E.Gathe JC. J. Am. Chem. Soc. 1950, 72: 1415 -
15a
Montalbetti CAGN.Falque V. Tetrahedron 2005, 61: 10827 -
15b
Tonolio C.Formaggio F.Kaptein B.Broxterman QB. Synlett 2006, 1295 -
15c
Bode JW. Curr. Opin. Drug Discovery Dev. 2006, 9: 765 -
15d
Valeur E.Bradley M. Chem. Soc. Rev. 2009, 38: 606 -
15e
Joullié MM.Lassen KM. ARKIVOC 2010, (viii): 189 -
15f
Shen B.Makley DM.Johnston JN. Nature 2010, 465: 1027
References
The filtrates were always transferred back to the reaction tubes and evaporated together with the remainder of the reaction mixtures. However, subsequent triturations with other solvents did not produce another portion of the corresponding product.